home / stock / immu / immu quote
Last: | $87.86 |
---|---|
Change Percent: | 0.05% |
Open: | $87.85 |
Close: | $87.86 |
High: | $87.93 |
Low: | $87.59 |
Volume: | 15,282,019 |
Last Trade Date Time: | 10/22/2020 04:56:50 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$87.86 | $87.85 | $87.86 | $87.93 | $87.59 | 15,282,019 | 10-22-2020 |
$87.82 | $87.75 | $87.82 | $87.82 | $87.72 | 5,345,257 | 10-21-2020 |
$87.72 | $87.68 | $87.72 | $87.725 | $87.65 | 2,934,955 | 10-20-2020 |
$87.61 | $87.62 | $87.61 | $87.6804 | $87.59 | 4,236,326 | 10-19-2020 |
$87.56 | $87.55 | $87.56 | $87.64 | $87.47 | 4,393,342 | 10-16-2020 |
$87.49 | $87.45 | $87.49 | $87.55 | $87.4 | 4,909,114 | 10-15-2020 |
$87.43 | $87.57 | $87.43 | $87.58 | $87.43 | 11,987,998 | 10-14-2020 |
$86.53 | $86.23 | $86.53 | $86.65 | $86.23 | 3,133,922 | 10-13-2020 |
$86.1 | $86.2 | $86.1 | $86.49 | $85.96 | 3,675,979 | 10-12-2020 |
$86 | $85.74 | $86 | $86.05 | $85.67 | 3,290,446 | 10-09-2020 |
$85.73 | $85.45 | $85.73 | $85.75 | $85.41 | 2,033,946 | 10-08-2020 |
$85.36 | $85.72 | $85.36 | $85.79 | $85.36 | 2,972,515 | 10-07-2020 |
$85.61 | $85.6 | $85.61 | $85.85 | $85.5 | 2,791,782 | 10-06-2020 |
$85.87 | $85.16 | $85.87 | $85.87 | $85.03 | 3,681,008 | 10-05-2020 |
$85.08 | $84.95 | $85.08 | $85.3 | $84.9 | 3,404,219 | 10-02-2020 |
$84.92 | $85.05 | $84.92 | $85.35 | $84.9 | 3,334,547 | 10-01-2020 |
$85.03 | $85.21 | $85.03 | $85.33 | $84.84 | 5,646,516 | 09-30-2020 |
$85.25 | $85.4 | $85.25 | $85.48 | $85.16 | 3,418,747 | 09-29-2020 |
$85.36 | $85.25 | $85.36 | $85.4 | $85.1 | 3,742,182 | 09-25-2020 |
$85.3 | $85.58 | $85.3 | $85.58 | $85.03 | 5,278,115 | 09-24-2020 |
News, Short Squeeze, Breakout and More Instantly...
Gilead Sciences (NASDAQ: GILD) can be both a hero and a goat, depending on your perspective as an investor. The stock price rose from $17 in July 2010 to $118 in July 2015, as the company introduced revolutionary HIV drugs and helped bring a cure for hepatitis C to market. Since the...
With huge investments being made in biotech thanks to the pandemic, there has been a renewed focus on biotech stocks. Here are three worth considering: Amgen (AMGN), Immunomedics (IMMU), Seattle Genetics (SGEN), and Genmab (GMAB). The biotechnology industry has rightfully received a huge ...
MORRIS PLAINS, N.J., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced that the Office of Orphan Products...